☰
Filter by:

Blog Posts

Filtered by: LC-MS
Challenging Pharmaceutical Impurity Analyses Part 1 – Derivatization – First Choice or Last Resort?
March 9, 2020 by Gemma Ellison Read
Top 3 Scan Modes to Consider for Small Molecule Quantitation on an Orbitrap Mass Spectrometer
February 24, 2020 by Monika (Verma) Bose Read
The Day the Clinical Trial Stood Still
January 8, 2020 by Jon Bardsley Read
Five Reasons to Implement LC-MS for Your LDTs
November 25, 2019 by Dr. Debadeep Bhattacharyya Read
Why Is Orbitrap-Based MS So Good for Analyzing NDMA Impurities in Zantac?
November 13, 2019 by Dr. Kyle D'Silva Read
Ensure Safer Biopharmaceuticals with Innovations in Host Cell Protein (HCP) Analysis
October 22, 2019 by Dr. Kelly Broster Read
Native Mass Spectrometry: The Tool of Choice for Accelerating Biopharmaceutical Drug Development
October 11, 2019 by Dr. Kelly Broster Read
Immunoassay or LC-MS?
October 4, 2019 by Dr. Timothy Cross Read
Pesticides on your plate!
August 26, 2019 by Ramiz M.R. Azad Read
The Dangers Lurking in Your Food Packaging
July 26, 2019 by Ed George Read
Quality by Design: Understanding How to Develop and Make Better Biologics
June 28, 2019 by Dr. Kelly Broster Read
5 More Reasons to Justify a New LCMS for Your Research Discoveries
June 17, 2019 by Dr. Scott Peterman Read
From Cake to Cloud, Data to Knowledge… (Part 2)
June 14, 2019 by Dr. Simon Cubbon Read

Industries

Resources

Contributors

Terms and Conditions | Privacy Statement | Trademarks | Cookie Usage

© Copyright 2020 Thermo Fisher Scientific Inc. All rights reserved.